Monashee Investment Management as of Sept. 30, 2022
Portfolio Holdings for Monashee Investment Management
Monashee Investment Management holds 52 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invesco Qqq Unit Ser 1 (QQQ) | 32.4 | $87M | 327k | 267.26 | |
| Vanguard Total Stock Mkt Etf Total Stk Mkt (VTI) | 31.5 | $85M | 474k | 179.47 | |
| Gossamer Bio (GOSS) | 3.1 | $8.3M | 694k | 11.98 | |
| Philip Morris International (PM) | 2.0 | $5.4M | 65k | 83.02 | |
| Corebridge Finl (CRBG) | 1.8 | $4.9M | 250k | 19.69 | |
| Argenx Se Sponsored Adr (ARGX) | 1.6 | $4.2M | 12k | 353.08 | |
| An2 Therapeutics (ANTX) | 1.5 | $4.1M | 233k | 17.38 | |
| Splunk Note 0.500% 9/1 | 1.4 | $3.8M | 4.0M | 0.95 | |
| Sylvamo Corp Common Stock (SLVM) | 1.1 | $3.1M | 90k | 33.90 | |
| Patrick Inds DBCV 1.000% 2/0 | 1.1 | $3.0M | 3.0M | 0.99 | |
| Wix Note 7/0 | 1.1 | $2.9M | 3.0M | 0.97 | |
| Somalogic Class A Com | 1.1 | $2.9M | 1.0M | 2.90 | |
| Western Digital Corp Note 1.500% 2/0 | 1.1 | $2.9M | 3.0M | 0.95 | |
| Compass Therapeutics (CMPX) | 1.0 | $2.8M | 1.2M | 2.28 | |
| Carnival Corp Common Stock (CCL) | 1.0 | $2.6M | 365k | 7.03 | |
| Dyne Therapeutics (DYN) | 0.9 | $2.5M | 200k | 12.70 | |
| Biohaven (BHVN) | 0.9 | $2.5M | 400k | 6.30 | |
| Core & Main Cl A (CNM) | 0.9 | $2.5M | 110k | 22.74 | |
| Revance Therapeutics (RVNC) | 0.9 | $2.3M | 85k | 27.00 | |
| Akero Therapeutics (AKRO) | 0.8 | $2.2M | 65k | 34.05 | |
| Pliant Therapeutics (PLRX) | 0.8 | $2.1M | 100k | 20.89 | |
| Sarepta Therapeutics Debt 1.250% 9/1 | 0.8 | $2.1M | 2.0M | 1.04 | |
| Alignment Healthcare (ALHC) | 0.7 | $1.9M | 160k | 11.84 | |
| Chinook Therapeutics | 0.7 | $1.9M | 95k | 19.66 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.6 | $1.7M | 220k | 7.91 | |
| Docgo (DCGO) | 0.6 | $1.7M | 175k | 9.92 | |
| Crescent Energy Cl A Com (CRGY) | 0.6 | $1.7M | 125k | 13.47 | |
| Fulcrum Therapeutics (FULC) | 0.6 | $1.6M | 200k | 8.09 | |
| Sofi Technologies (SOFI) | 0.6 | $1.6M | 320k | 4.88 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $1.5M | 192k | 7.76 | |
| Profrac Holding Corp Class A Com (ACDC) | 0.5 | $1.4M | 95k | 15.21 | |
| Illumina Note 8/1 | 0.5 | $1.4M | 1.5M | 0.96 | |
| First Republic Bank/san F (FRCB) | 0.5 | $1.3M | 10k | 130.60 | |
| 8X8 Note 0.500% 2/0 | 0.5 | $1.3M | 1.5M | 0.85 | |
| Altus Power Com Cl A (AMPS) | 0.4 | $1.2M | 109k | 11.01 | |
| Paycor Hcm (PYCR) | 0.4 | $1.0M | 35k | 29.57 | |
| 2seventy Bio Common Stock (TSVT) | 0.4 | $1.0M | 70k | 14.56 | |
| Cincor Pharma | 0.4 | $985k | 30k | 32.83 | |
| Ideaya Biosciences (IDYA) | 0.3 | $895k | 60k | 14.92 | |
| Third Harmonic Bio (THRD) | 0.3 | $759k | 40k | 18.98 | |
| Alpine Immune Sciences (ALPN) | 0.3 | $720k | 100k | 7.20 | |
| Relay Therapeutics (RLAY) | 0.3 | $680k | 30k | 22.37 | |
| Mirum Pharmaceuticals (MIRM) | 0.2 | $630k | 30k | 21.00 | |
| Alnylam Pharmaceuticals (ALNY) | 0.2 | $600k | 3.0k | 200.00 | |
| New Relic Note 0.500% 5/0 | 0.2 | $491k | 500k | 0.98 | |
| Smartrent Com Cl A (SMRT) | 0.2 | $454k | 200k | 2.27 | |
| LSB Industries (LXU) | 0.2 | $449k | 32k | 14.25 | |
| Patria Investments Com Cl A (PAX) | 0.1 | $392k | 30k | 13.07 | |
| Bellus Health Com New | 0.1 | $317k | 30k | 10.57 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.1 | $232k | 369k | 0.63 | |
| Knowbe4 Cl A | 0.1 | $208k | 10k | 20.80 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $23k | 127k | 0.18 |
